Specified Drug-use Surveillance of Fabhalta Capsules

Clinical trial NCT06606314 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06606314
Sponsor: Novartis Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Paroxysmal Nocturnal Hemoglobinuria

Start date: 2024-09-18
Primary completion: 2028-09-30
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.